Israeli drug development company Kitov Pharma (NASDAQ:KITOV), saw its stock surge again yesterday after announcing that it has closed its registered direct offering of 38,888,892 of the company’s ordinary shares, raising approximately $35 million.
The company said they want to use the proceeds from the offering to fund the development of its oncology drugs, acquire new assets and use it as general working capital.
Ready to put what you’ve learned into practice?
Try IG’s platform with £10,000 in virtual funds and practise trading
without putting your own money at risk.
Try IG with a demo account →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Learn the markets with IG Academy
Build your knowledge with IG Academy educational content, then use a
demo account to practise what you’ve learned on the IG platform.
Explore IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
See how trading works before risking real money
IG’s demo gives you access to thousands of markets and £10,000 in
virtual funds, so you can explore the platform and test your ideas first.
Open an IG demo →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Turn trading theory into practical experience
Learn with IG Academy, explore charts and market tools, and practise
strategies in a simulated trading environment before going live.
Start practising with IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Ready to take your learning further?
IG combines market education, analysis and an established trading platform,
giving you the tools to keep learning as you develop your trading skills.
Discover IG →
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when trading spread bets and CFDs with this provider.
Kitov’s shares had jumped 100% over the past few days which was helped by the president of Barstool Sports and leader of a new wave of retail traders, Dave Portnoy saying that he had bought the stock.
Then a report came out this week via “Seeking Alpha” that the rise in its share price was due to Kitov planning to collaborate with Bristol Myers Squibb for a cancer treatment drug. Although it must be said that the rumour hasn’t been confirmed.
Regardless of why the move happened, it seems that the company has taken advantage of the clamour for its stock and chosen to sell more shares to healthcare-focused institutional investors.
It seems to have paid off as yesterday the company’s share price rose another 46%, closing out the day at $1.26 having reached as high as $1.40 earlier in the day.
There is a crucial level around the $1 area which will need to be watched for any potential pullbacks.
